1. Home
  2. |Insights
  3. |Public-Private Partnerships On The Rise

Public-Private Partnerships On The Rise

Client Alert | less than 1 min read | 04.22.09

In "Funding America's Infrastructure Needs: Public-Private Partnerships May Help Close Infrastructure Gap," in the March 2009 issue of Construction Briefings, Steve McBrady of C&M examines the increasing use of Public-Private Partnerships (PPPs) in American infrastructure, as the federal government, states, and localities seek innovative mechanisms for upgrading and operating critical infrastructure. The recently passed American Recovery and Reinvestment Act of 2009, the Obama administration's proposal for a National Infrastructure Reinvestment Bank, and the upcoming Transportation Re-Authorization bill, will bolster these efforts and generate increased focus on the use of PPPs across the country.

Contacts

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights